X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-24 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.34 | -583,657 | 6,066,343 | -9% | -$197,239 | |||||
| M | 2025-04-22 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.33 | -235,572 | 6,650,000 | -3% | -$78,731 | |||||
| M | 2025-04-15 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.33 | -149,054 | 6,885,572 | -2% | -$49,704 | |||||
| D | 2025-02-11 | PASG | Borthwick Kathleen | CFO | S - Sale+OE | $0.53 | -3,183 | 41,283 | -7% | -$1,686 | |||||
| M | 2025-01-10 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.64 | -223,219 | 7,034,626 | -3% | -$142,223 | |||||
| M | 2025-01-06 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.70 | -147,024 | 7,257,845 | -2% | -$103,306 | |||||
2024-12-27 | PASG | Lynx1 Capital Management LP | 10% | P - Purchase | $0.65 | +373,645 | 9,256,953 | +4% | +$241,038 | ||||||
2024-12-20 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.60 | -230,321 | 7,404,869 | -3% | -$138,193 | ||||||
| M | 2024-12-09 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.83 | -62,276 | 7,635,190 | -1% | -$51,988 | |||||
| M | 2024-12-04 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.80 | -97,103 | 7,697,466 | -1% | -$77,338 | |||||
| M | 2024-11-25 | PASG | Lynx1 Capital Management LP | 10% | P - Purchase | $0.62 | +456,353 | 17,570,261 | +3% | +$284,520 | |||||
2024-09-19 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.71 | -39,300 | 7,794,569 | -1% | -$27,903 | ||||||
| M | 2024-09-16 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.73 | -200,131 | 7,833,869 | -2% | -$146,727 | |||||
| D | 2024-02-13 | PASG | Borthwick Kathleen | SVP, Interim CFO | S - Sale+OE | $0.97 | -1,470 | 28,466 | -5% | -$1,426 | |||||
| D | 2024-02-13 | PASG | Forman Mark S | Chief Medical Officer | S - Sale+OE | $0.97 | -1,638 | 48,631 | -3% | -$1,589 | |||||
| D | 2024-01-02 | PASG | Forman Mark S | Chief Medical Officer | S - Sale+OE | $0.91 | -15,813 | 45,269 | -26% | -$14,390 | |||||
| D | 2024-01-02 | PASG | Borthwick Kathleen | SVP, Interim CFO | S - Sale+OE | $0.91 | -10,672 | 25,936 | -29% | -$9,712 | |||||
| D | 2024-01-02 | PASG | Cale Edgar B. | GC, Corporate Secretary | S - Sale+OE | $0.91 | -15,813 | 45,995 | -26% | -$14,390 | |||||
| D | 2023-07-28 | PASG | King Simona | CFO | S - Sale+OE | $0.88 | -11,453 | 23,994 | -32% | -$10,079 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |